论文部分内容阅读
本文测定白血病和淋巴瘤患者RCIA与RBC SOD活性,结果显示白血病和淋巴瘤患者RCIA活性均明显低于正常人(p<0.01);白血病患者RBC SOD活性明显降低而淋巴瘤患者则增高(P<0.01),两种疾病的RCIA活性降低与RBC SOD活性变化无关系
The results of RCIA and RBC SOD assays in patients with leukemia and lymphoma showed that RCIA activity in patients with leukemia and lymphoma was significantly lower than that in normal subjects (p <0.01); RBC SOD activity was significantly decreased in patients with leukemia and increased in patients with lymphoma (P < 0.01). The decrease of RCIA activity in both diseases had no relation with the change of RBC SOD activity